Iman Ragab

593 total citations
37 papers, 269 citations indexed

About

Iman Ragab is a scholar working on Hematology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Iman Ragab has authored 37 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Surgery and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Iman Ragab's work include Vascular Malformations and Hemangiomas (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Iman Ragab is often cited by papers focused on Vascular Malformations and Hemangiomas (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Iman Ragab collaborates with scholars based in Egypt, United States and Saudi Arabia. Iman Ragab's co-authors include Eman Abdel Rahman Ismail, Amira Adly, Mohsen Saleh Elalfy, Azza Abdel Gawad Tantawy, Shaimaa Nasr Amin, Alaa F. Hamza, Mohamed M. Aly, Mohammed Tarif Hamza, Galila M. Mokhtar and Valeria Bozzi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and EMBO Molecular Medicine.

In The Last Decade

Iman Ragab

28 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iman Ragab Egypt 9 114 65 58 53 41 37 269
Alex Wing Kwan Leung Hong Kong 12 111 1.0× 82 1.3× 42 0.7× 66 1.2× 94 2.3× 51 380
Oya Levendoglu‐Tugal United States 12 177 1.6× 39 0.6× 36 0.6× 35 0.7× 26 0.6× 24 351
Manas Kalra India 9 59 0.5× 53 0.8× 41 0.7× 19 0.4× 65 1.6× 55 278
Ghaleb Elyamany Saudi Arabia 11 124 1.1× 68 1.0× 32 0.6× 41 0.8× 22 0.5× 49 393
Chalinee Monsereenusorn Thailand 8 73 0.6× 57 0.9× 18 0.3× 59 1.1× 54 1.3× 38 241
Carolyn Fein Levy United States 10 73 0.6× 51 0.8× 50 0.9× 148 2.8× 32 0.8× 23 334
Zümrüt Uysal Türkiye 12 217 1.9× 139 2.1× 29 0.5× 40 0.8× 40 1.0× 51 374
JUAN F MARTINEZ ORTEGA Spain 11 138 1.2× 24 0.4× 69 1.2× 27 0.5× 34 0.8× 16 292
Noémie Abisror France 11 69 0.6× 37 0.6× 135 2.3× 27 0.5× 22 0.5× 33 409
Karen Mandel Canada 7 86 0.8× 49 0.8× 23 0.4× 21 0.4× 75 1.8× 13 280

Countries citing papers authored by Iman Ragab

Since Specialization
Citations

This map shows the geographic impact of Iman Ragab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Ragab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Ragab more than expected).

Fields of papers citing papers by Iman Ragab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iman Ragab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Ragab. The network helps show where Iman Ragab may publish in the future.

Co-authorship network of co-authors of Iman Ragab

This figure shows the co-authorship network connecting the top 25 collaborators of Iman Ragab. A scholar is included among the top collaborators of Iman Ragab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iman Ragab. Iman Ragab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ragab, Iman, et al.. (2025). Immunodeficiency in children with Diamond Blackfan and Diamond Blackfan like anemia. Blood Cells Molecules and Diseases. 111. 102911–102911.
2.
Tantawy, Azza Abdel Gawad, et al.. (2024). Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome. Expert Review of Hematology. 17(4-5). 153–163. 1 indexed citations
3.
AbouZeid, Amr Abdelhamid, et al.. (2023). Lymphatic malformations: a 9-year experience at the vascular anomaly clinic. SHILAP Revista de lepidopterología. 71(1). 1 indexed citations
4.
Mokhtar, Galila M., Ahmed M. Youssef, Ilham Youssry, et al.. (2023). Evidence-based Egyptian clinical practice guidelines: for the prevention and management of iron deficiency and iron deficiency anemia in infants, children and adolescents. SHILAP Revista de lepidopterología. 47(1). 1 indexed citations
5.
Ragab, Iman, et al.. (2023). Assessment of vascular endothelial growth factor a serum level in pediatric hemophilic arthropathy. SHILAP Revista de lepidopterología. 50(1).
6.
Elalfy, Mohsen Saleh, et al.. (2023). A stepwise diagnostic approach for undiagnosed Anemia in children: A model for low-middle income country. Blood Cells Molecules and Diseases. 103. 102779–102779. 2 indexed citations
7.
Ragab, Iman, et al.. (2021). Evaluation of Sickle Cell Module for Quality of Life in Egyptian Children and Adolescents Patients: Impact of Psychiatric and Disease Specific Variables. Indian Journal of Hematology and Blood Transfusion. 37(4). 616–622. 2 indexed citations
8.
Tantawy, Azza Abdel Gawad, et al.. (2021). Treatment outcomes for childhood acute lymphoblastic leukemia in low-middle income country before minimal residual disease risk stratification. Cancer Epidemiology. 75. 102040–102040. 2 indexed citations
9.
AbouZeid, Amr Abdelhamid, et al.. (2021). Differential diagnostic features between congenital haemangioma, KHE, and congenital fibrosarcoma: a single-centre experience. European Journal of Pediatrics. 180(8). 2581–2589.
10.
Tantawy, Azza Abdel Gawad, et al.. (2020). Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates. Pediatric Hematology and Oncology. 37(8). 696–706. 2 indexed citations
11.
12.
Pecci, Alessandro, Iman Ragab, Valeria Bozzi, et al.. (2017). Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim. EMBO Molecular Medicine. 10(1). 63–75. 41 indexed citations
13.
Ragab, Iman, et al.. (2017). Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: Role of immature platelet fraction. Congenital Heart Disease. 13(1). 118–123. 10 indexed citations
14.
Aly, Mohamed M., et al.. (2015). Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. European Journal of Pediatrics. 174(11). 1503–1509. 27 indexed citations
15.
Ragab, Iman, et al.. (2015). Study of alpha hemoglobin stabilizing protein expression in patients with β thalassemia and sickle cell anemia and its impact on clinical severity. Blood Cells Molecules and Diseases. 55(4). 358–362. 10 indexed citations
16.
Elalfy, Mohsen Saleh, et al.. (2014). Neurocognitive Outcome and White Matter Anisotropy in Childhood Acute Lymphoblastic Leukemia Survivors Treated with Different Protocols. Pediatric Hematology and Oncology. 31(2). 194–204. 32 indexed citations
17.
Adly, Amira, et al.. (2014). Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets. 26(7). 645–650. 48 indexed citations
18.
Ragab, Iman, et al.. (2013). Effect of Using Bedside Leukocyte Filter on Pulmonary Functions in Patients with Thalassemia Major. Pediatric Hematology and Oncology. 30(8). 761–767.
19.
Tantawy, Azza Abdel Gawad, et al.. (2012). Pathogenesis and Prognosis of Neutropenia in Infants and Children Admitted in a University Children Hospital in Egypt. Pediatric Hematology and Oncology. 30(1). 51–59. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex Wing Kwan Leung Breakdown of academic impact, for papers by Oya Levendoglu‐Tugal Breakdown of academic impact, for papers by Manas Kalra Breakdown of academic impact, for papers by Ghaleb Elyamany Breakdown of academic impact, for papers by Chalinee Monsereenusorn Breakdown of academic impact, for papers by Carolyn Fein Levy Breakdown of academic impact, for papers by Zümrüt Uysal Breakdown of academic impact, for papers by JUAN F MARTINEZ ORTEGA Breakdown of academic impact, for papers by Noémie Abisror Breakdown of academic impact, for papers by Karen Mandel
Rankless by CCL
2026